Koons on Pfizer Agreeing to Buy Medivati...

Brad Smith, President of Microsoft, discusses updated content from his book "Tools and Weapons: The Promise and the Peril of the Digital Age." Jennifer Surane, Finance Reporter for Bloomberg News, talks about her story, "Wall Street Limps Into Post-Labor Day Return Derailed by De ... Show More

Phil Orlando, Chief Equity Market Strategist and Head of Client Portfolio Management at Federated Hermes, talks jobs and markets. Skylar Woodhouse, Reporter for Bloomberg News, discusses the aftermath of Hurricane Ida in New York City. Tom Bohn, President & CEO of the Association ... Show More

David Riley, Chief Investment Strategist at BlueBay Asset Management, previews jobs day. Rebecca Ray, Executive Vice President, Human Capital at The Conference Board, discusses their return to work study. Brian Fields, Groupon’s Chief Commercial Officer, talks trending stay-catio ... Show More

Bloomberg BNA's Eleanor Tyler joins Tom Keene and Mike McKee to discuss pharmaceutical mergeres, tax inversions, drug pricing, and the renewed efforts by the Federal Trade Commission to regulate an increasingly complicated industry. Learn more about your ad-choices at https://www ... Show More

In the first of two episodes this week, we're taking a deep dive into the pharmaceutical industry. How much does the medication you take actually cost? What if a company came along and bought the rights to a particular drug and started charging double, triple, or even 10,000 time ... Show More

Ireland-based biopharmaceutical company Jazz Pharmaceuticals buys the biggest acquisition in the cannabis industry to date after agreeing to buy GW Pharmaceuticals for $7.2 billion last week. Learn more about your ad-choices at https://www.iheartpodcastnetwork.comSee omnystudio.c ... Show More

In today's episode, we discuss issues in the pharmaceutical industry, how pharmacists are dealing with the pandemic, and how the role of the pharmacist is evolving. "If you don't want to be in the business of serving, then get out of pharmacy." - Todd Eury Take the Corepreneur Se ... Show More

On this week's episode of Networth and Chill, I'm joined by author and CEO of Rhoshan Pharmaceuticals, Hitha Palepu to talk drug prices and the pharmaceutical industry. Drug prices are a hot topic these days, and it seems like the cost of life saving medications like insulin and ... Show More

In the past month pharmaceutical companies have spent almost $100bn acquiring biotech companies. The FT's Sarah Neville explains why big pharma is raising its bet on the drug pipelines owned by biotechs, and why analysts expect more consolidation in 2019.  Read more from Sarah at ... Show More

BTIG's Dane Leone discusses healthcare and consolidation between companies. He speaks with Michael McKee and David Gura on Bloomberg Surveillance. Learn more about your ad-choices at https://www.iheartpodcastnetwork.com